SCHEMBL20323596

SCHEMBL20323596

CNC(=O)Nc1ccc(N(C)C)nc1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 3/20 0.50
ALDH1A1 P00352 3/20 0.47
PIK3CA P42336 3/20 0.45
MTOR P42345 2/20 0.45
NAMPT P43490 1/20 0.43
KMT2A Q03164 2/20 0.42
KDM1A O60341 1/20 0.42
P4HTM Q9NXG6 1/20 0.40
KDM4E B2RXH2 1/20 0.40
HPGD P15428 1/20 0.40
PIP4K2A P48426 1/20 0.40
PIP4K2B P78356 1/20 0.40
POLB P06746 2/20 0.40
MEN1 O00255 1/20 0.39
PABPC1 P11940 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
RECQL P46063 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
SLC2A1 P11166 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12047250 0.85 TRPV1 (0.49) TRPV1PIK3CAMTORNAMPTKMT2A
SCHEMBL15962680 0.83 TRPV1 (0.52) TRPV1ALDH1A1PIK3CAMTORKMT2A
SCHEMBL25202900 0.83 TRPV1 (0.52) TRPV1PIK3CAMTORNAMPTKDM1A
SCHEMBL20057529 0.81 TRPV1 (0.51) TRPV1ALDH1A1PIK3CAMTORKMT2A
SCHEMBL29678557 0.78 MAPT (0.60) TRPV1ALDH1A1PIK3CAMTORKMT2A
SCHEMBL12049698 0.77 NPSR1 (0.60) ALDH1A1PIK3CAMTORNAMPTKMT2A
SCHEMBL14289818 0.77 ALDH1A1 (0.52) ALDH1A1KMT2AKDM4EHPGDPIP4K2A
SCHEMBL30828557 0.76 P4HTM (0.57) TRPV1PIK3CAMTORNAMPTP4HTM
SCHEMBL19782986 0.76 KDM1A (0.50) TRPV1PIK3CAMTORNAMPTKDM1A
SCHEMBL20323595 0.76 HCAR3 (0.51) ALDH1A1KMT2AKDM4EHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10351522-B2 Sulfonamide derivative and pharmaceutically acceptable acid addition salt thereof UNIVERSITY OF TSUKUBA (JP) 2019-07-16 US disclosed
US-20180179151-A1 SULFONAMIDE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALT THEREOF UNIVERSITY OF TSUKUBA (JP) 2018-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180179151-A1 SULFONAMIDE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALT THEREOF HCRTR2, HCRTR1, NPSR1 TRPV1 14/4885ALDH1A1 968/4885PIK3CA 4650/4885
US-10351522-B2 Sulfonamide derivative and pharmaceutically acceptable acid addition salt thereof HCRTR2, HCRTR1, NPSR1 TRPV1 14/4885ALDH1A1 968/4885PIK3CA 4650/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.